Geis Abby L, Fan Hongni, Wu Xinqun, Wu Shaoguang, Huso David L, Wolfe Jaime L, Sears Cynthia L, Pardoll Drew M, Housseau Franck
Department of Oncology and the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Cancer Discov. 2015 Oct;5(10):1098-109. doi: 10.1158/2159-8290.CD-15-0447. Epub 2015 Jul 22.
Many epithelial cancers are associated with chronic inflammation. However, the features of inflammation that are procarcinogenic are not fully understood. Regulatory T cells (Treg) typically restrain overt inflammatory responses and maintain intestinal immune homeostasis. Their immune-suppressive activity can inhibit inflammation-associated cancers. Paradoxically, we show that colonic Tregs initiate IL17-mediated carcinogenesis in multiple intestinal neoplasia mice colonized with the human symbiote enterotoxigenic Bacteroides fragilis (ETBF). Depletion of Tregs in ETBF-colonized C57BL/6 FOXP3(DTR) mice enhanced colitis but diminished tumorigenesis associated with shifting of mucosal cytokine profile from IL17 to IFNγ; inhibition of ETBF-induced colon tumorigenesis was dependent on reduced IL17 inflammation and was independent of IFNγ. Treg enhancement of IL17 production is cell-extrinsic. IL2 blockade restored Th17 responses and tumor formation in Treg-depleted animals. Our findings demonstrate that Tregs limit the availability of IL2 in the local microenvironment, allowing the Th17 development necessary to promote ETBF-triggered neoplasia, and thus unveil a new mechanism whereby Treg responses to intestinal bacterial infection can promote tumorigenesis.
Tregs promote an oncogenic immune response to a common human symbiote associated with inflammatory bowel disease and colorectal cancer. Our data define mechanisms by which mucosal Tregs, despite suppressing excessive inflammation, promote the earliest stages of immune procarcinogenesis via enhancement of IL17 production at the expense of IFNγ production.
许多上皮性癌症与慢性炎症相关。然而,促癌的炎症特征尚未完全明确。调节性T细胞(Treg)通常会抑制明显的炎症反应并维持肠道免疫稳态。它们的免疫抑制活性可抑制与炎症相关的癌症。矛盾的是,我们发现,在定植了人类共生体产肠毒素脆弱拟杆菌(ETBF)的多肠道肿瘤小鼠中,结肠Treg会引发IL17介导的致癌作用。在ETBF定植的C57BL/6 FOXP3(DTR)小鼠中清除Treg可增强结肠炎,但会减少与黏膜细胞因子谱从IL17向IFNγ转变相关的肿瘤发生;抑制ETBF诱导的结肠肿瘤发生依赖于IL17炎症的减少,且与IFNγ无关。Treg对IL17产生的增强作用是细胞外的。阻断IL2可恢复Treg缺失动物的Th17反应和肿瘤形成。我们的研究结果表明,Treg限制了局部微环境中IL2的可用性,从而允许促进ETBF引发的肿瘤形成所必需的Th17发育,进而揭示了一种新机制,即Treg对肠道细菌感染的反应可促进肿瘤发生。
Treg促进对一种与炎症性肠病和结直肠癌相关的常见人类共生体的致癌免疫反应。我们的数据确定了黏膜Treg尽管抑制过度炎症,但仍通过增强IL17产生而以牺牲IFNγ产生为代价促进免疫促癌最早阶段的机制。